A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank-Reference-Cited by-同舟云学术

A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank

Published:2020-06 Issue:6 Volume:72 Page:1070-1081
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Walker Ryan W.,Belbin Gillian M.,Sorokin Elena P.,Van Vleck Tielman,Wojcik Genevieve L.,Moscati Arden,Gignoux Christopher R.,Cho Judy,Abul-Husn Noura S.,Nadkarni Girish,Kenny Eimear E.,Loos Ruth J.F.

Funder

National Institutes of Health

National Institute of Child Health and Human Development

National Human Genome Research Institute

National Institute on Minority Health and Health Disparities

NHGRI

National Heart, Lung, and Blood Institute

NIMHD

NHLBI

National Institute of Diabetes and Kidney and Digestive Disease

NIH

Publisher

Elsevier BV

Subject

Hepatology

Reference53 articles.

1. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008;Younossi;Clin Gastroenterol Hepatol,2011

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

3. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

4. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;Williams;Gastroenterology,2011

5. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The health care experience of adults with metabolic dysfunction–associated steatohepatitis and influence of PNPLA3: A qualitative study;Hepatology Communications;2024-05-22

2. Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?;United European Gastroenterology Journal;2024-04-24

3. PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease;Hepatology;2024-04-23

4. Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease;Metabolism and Target Organ Damage;2024-02-26

5. A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver;2024-01-27